Breast Cancer Research and Treatment

, Volume 88, Issue 3, pp 281–285

The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality

Commentary

Abstract

Breast cancer prognosis differs among racial and ethnic groups. Though the incidence of breast cancer is lower in African–Americans than in Caucasians, mortality is higher. While socioeconomic, psychosocial, and lifestyle issues are undoubtedly important in such disparities, genetic factors that differ among populations and that are involved in the molecular pathways regulating tumor development may also play roles. In this communication, I summarize recent investigations of the gene encoding the pro-inflammatory cytokine interleukin-6 (IL-6), and suggest that this gene is a susceptibility factor that determines racial and/or ethnic differences in breast cancer survival. Published studies of a G/C polymorphism at nucleotide -174 within the promoter region of the IL-6gene are consistent with this suggestion. This polymorphism alters expression of the cytokine. In addition, allele and genotype frequencies at the -174 site differ dramatically among racial and ethnic groups. Finally, the variant genotypes are associated with alterations in breast cancer survival. In all, these observations argue for additional studies of the IL-6 gene polymorphism as a predisposing genetic factor that contributes to racial and ethnic differences in breast cancer prognosis.

Keywords

breast cancer interleukin-6 polymorphism racial/ethnic disparities 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Trock, BJ 1996Breast cancer in African American women: epidemiology and tumor biologyBreast Cancer Res Treat401124Google Scholar
  2. Ademuyiwa, FO, Olopade, OI 2003Racial differences in genetic factors associated with breast cancerCancer Metastasis Rev224753Google Scholar
  3. Hunter, CP 2000Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populationsCancer8811931202Google Scholar
  4. Li, CI, Malone, KE, Daling, JR 2002Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and olderCancer Epidemiol Biomarkers Prev11601607Google Scholar
  5. Shinagawa, SM 2000The excess burden of breast carcinoma in minority and medically underserved communities: application, research, and redressing institutional racismCancer8812171223Google Scholar
  6. Ward, E, Jemal, A, Cokkinides, V, Singh, GK, Cardinez, C, Ghafoor, A, Thun, M 2004Cancer disparities by race/ethnicity and socioeconomic statusCA Cancer J Clin547893Google Scholar
  7. Zaloznik, AJ 1995Breast cancer stage at diagnosis: caucasians versus Afro-AmericansBreast Cancer Res Treat34195198Google Scholar
  8. Pearlman, DN, Rakowski, W, Ehrich, B, Clark, MA 1996Breast cancer screening practices among black, Hispanic, and white women: reassessing differencesAm J Prev Med12327337Google Scholar
  9. Eley, JW, Hill, HA, Chen, VW, Austin, DF, Wesley, MN, Muss, HB, Greenberg, RS, Coates, RJ, Correa, P, Redmond, CK,  et al. 1994Racial differences in survival from breast cancerResults of the National Cancer Institute Black/White Cancer Survival Study. JAMA272947954Google Scholar
  10. Elledge, RM, Clark, GM, Chamness, GC, Osborne, CK 1994Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United StatesJ Natl Cancer Inst86705712Google Scholar
  11. Wiencke, JK 2004Impact of race/ethnicity on molecular pathways in human cancerNat Rev Cancer47984Google Scholar
  12. Gao, Q, Neuhausen, S, Cummings, S, Luce, M, Olopade, OI 1997Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancerAm J Hum Genet6012331236Google Scholar
  13. Taioli, E, Trachman, J, Chen, X, Toniolo, P, Garte, SJ 1995A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African–American womenCancer Res5537573758Google Scholar
  14. Guillemette, C, Millikan, RC, Newman, B, Housman, DE 2000Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1Al and association with breast cancer among African AmericansCancer Res60950956Google Scholar
  15. Guillemette, C, Vivo, I, Hankinson, SE, Haiman, CA, Spiegelman, D, Housman, DE, Hunter, DJ 2001Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levelsCancer Epidemiol Biomarkers Prev10711714Google Scholar
  16. Hirano, T 1998Interleukin 6 and its receptor: ten years laterInt Rev Immunol16249284Google Scholar
  17. Leu, CM, Wong, FH, Chang, C, Huang, SF, Hu, CP 2003Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathwaysOncogene2278097818Google Scholar
  18. Brocke-Heidrich, K, Kretzschmar, AK, Pfeifer, G, Henze, C, Loffler, D, Koczan, D, Thiesen, HJ, Burger, R, Gramatzki, M, Horn, F 2004Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activationBlood103242251Google Scholar
  19. Trikha, M, Corringham, R, Klein, B, Rossi, JF 2003Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidenceClin Cancer Res946534665Google Scholar
  20. Nakashima, J, Tachibana, M, Horiguchi, Y, Oya, M, Ohigashi, T, Asakura, H, Murai, M 2000Serum interleukin 6 as a prognostic factor in patients with prostate cancerClin Cancer Res627022706Google Scholar
  21. Chung, YC, Chang, YF 2003Serum interleukin-6 levels reflect the disease status of colorectal cancerJ Surg Oncol83222226Google Scholar
  22. Bhat-Nakshatri, P, Campbell, RA, Patel, NM, Newton, TR, King, AJ, Marshall, MS, Ali, S, Nakshatri, H 2004Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression functionBr J Cancer90853859Google Scholar
  23. Fishman, D, Faulds, G, Jeffery, R, Mohamed-Ali, V, Yudkin, JS, Humphries, S, Woo, P 1998The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisJ Clin Invest10213691376Google Scholar
  24. Belluco, C, Olivieri, F, Bonafe, M, Giovagnetti, S, Mammano, E, Scalerta, R, Ambrosi, A, Franceschi, C, Nitti, D, Lise, M 2003-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancerClin Cancer Res921732176Google Scholar
  25. Rivera-Chavez, FA, Peters-Hybki, DL, Barber, RC, O’Keefe, GE 2003Interleukin-6 promoter haplotypes and interleukin-6 cytokine responsesShock20218223Google Scholar
  26. Terry, CF, Loukaci, V, Green, FR 2000Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulationJ Biol Chem2751813818144Google Scholar
  27. Christiansen, L, Bathum, L, Andersen-Ranberg, K, Jeune, B, Christensen, K 2004Modest implication of interleukin-6 promoter polymorphisms in longevityMech Ageing Dev125391395Google Scholar
  28. Georges, JL, Loukaci, V, Poirier, O, Evans, A, Luc, G, Arveiler, D, Ruidavets, JB, Cambien, F, Tiret, L 2001Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECITM studyEtude Cas-Temoin de 1’Infarctus du Myocarde. J Mol Med79300305Google Scholar
  29. Jones, KG, Brull, DJ, Brown, LC, Sian, M, Greenhalgh, RM, Humphries, SE, Powell, JT 2001Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysmsCirculation10322602265Google Scholar
  30. Bruunsgaard, H, Christiansen, L, Pedersen, AN, Schroll, M, Jorgensen, T, Pedersen, BK 2004The IL-6 -174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humansExp Gerontol39255261Google Scholar
  31. Cox, ED, Hoffmann, SC, DiMercurio, BS, Wesley, RA, Harlan, DM, Kirk, AD, Blair, PJ 2001Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6Transplantation72720726Google Scholar
  32. Meenagh, A, Williams, F, Ross, OA, Patterson, C, Gorodezky, C, Hammond, M, Leheny, WA, Middleton, D 2002Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South AmericaHum Immunol6310551061Google Scholar
  33. Hassan, MI, Aschner, Y, Manning, CH, Xu, J, Aschner, JL 2003Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North CarolinaCytokine211016Google Scholar
  34. Vozarova, B, Fernandez-Real, JM, Knowler, WC, Gallart, L, Hanson, RL, Gruber, JD, Ricart, W, Vendrell, J, Richart, C, Tataranni, PA,  et al. 2003The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and CaucasiansHum Genet112409413Google Scholar
  35. Simhan, HN, Krohn, MA, Roberts, JM, Zeevi, A, Caritis, SN 2003Interleukin-6 promoter -174 polymorphism and spontaneous preterm birthAm J Obstet Gynecol189915918Google Scholar
  36. Harding, D, Dhamrait, S, Millar, A, Humphries, S, Marlow, N, Whitelaw, A, Montgomery, H 2003Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infantsPediatrics112800803Google Scholar
  37. Rundek, T, Elkind, MS, Pittman, J, Boden-Albala, B, Martin, S, Humphries, SE, Juo, SH, Sacco, RL 2002Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort StudyStroke3314201423Google Scholar
  38. Fernandez-Real, JM, Broch, M, Vendrell, J, Richart, C, Ricart, W 2000Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjectsJ Clin Endocrinol Metab8513341339Google Scholar
  39. Hefler, LA, Grimm, C, Ackermann, S, Malur, S, Radjabi-Rahat, AR, Leodolter, S, Beckmann, MW, Zeillinger, R, Koelbl, H, Tempfer, CB 2003An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancerCancer Res6330663068Google Scholar
  40. Landi, S, Moreno, V, Gioia-Patricola, L, Guino, E, Navarro, M, Oca, J, Capella, G, Canzian, F 2003Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancerCancer Res6335603566Google Scholar
  41. Foster, CB, Lehrnbecher, T, Samuels, S, Stein, S, Mol, F, Metcalf, JA, Wyvill, K, Steinberg, SM, Kovacs, J, Blauvelt, A,  et al. 2000An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusBlood9625622567Google Scholar
  42. Cozen, W, Gill, PS, Ingles, SA, Masood, R, Martinez-Maza, O, Cockbura, MF, Gauderman, WJ, Pike, MC, Bernstein, L, Nathwani, BN,  et al. 2004IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphomaBlood10332163221Google Scholar
  43. DeMichele, A, Martin, AM, Mick, R, Gor, P, Wray, L, Klein-Cabral, M, Athanasiadis, G, Colligan, T, Stadtmauer, E, Weber, B 2003Interleukin-6 -174G->C polymorphism is associated with improved outcome in high-risk breast cancerCancer Res6380518056Google Scholar
  44. Iacopetta, B, Grieu, F, Joseph, D 2004The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotypeBr J Cancer90419422Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  1. 1.Department of Biological Sciences, Coker Life Sciences BuildingUniversity of South CarolinaColumbiaUSA

Personalised recommendations